PhaseRx, Inc.
PZRXQ · OTC
12/31/2016 | 12/31/2015 | 12/31/2014 | |
|---|---|---|---|
| Market Cap | $11,662 | $39,568 | $29,593 |
| - Cash | $9,983 | $3,290 | $2,031 |
| + Debt | $5,703 | $19,841 | $12,540 |
| Enterprise Value | $7,382 | $56,119 | $40,102 |
| Revenue | $0 | $375 | $1,200 |
| % Growth | -100% | -68.8% | – |
| Gross Profit | $0 | $375 | $1,200 |
| % Margin | – | 100% | 100% |
| EBITDA | -$17,943 | -$5,397 | -$4,970 |
| % Margin | – | -1,439.2% | -414.2% |
| Net Income | -$20,137 | -$7,377 | -$6,849 |
| % Margin | – | -1,967.2% | -570.8% |
| EPS Diluted | -2.68 | -0.94 | -1.16 |
| % Growth | -185.1% | 19% | – |
| Operating Cash Flow | -$9,811 | -$5,980 | -$4,861 |
| Capital Expenditures | -$171 | -$114 | -$53 |
| Free Cash Flow | -$9,982 | -$6,094 | -$4,914 |